Nj State Employees Deferred Compensation Plan Acadia Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 17,000 shares of ACAD stock, worth $340,680. This represents 0.04% of its overall portfolio holdings.
Number of Shares
17,000
Previous 17,000
-0.0%
Holding current value
$340,680
Previous $261,000
19.16%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ACAD
# of Institutions
314Shares Held
164MCall Options Held
855KPut Options Held
362K-
Baker Bros. Advisors LP New York, NY42.9MShares$859 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$280 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$242 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$174 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$146 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.24B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...